| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.37 | 0.2 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |